+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotrophic Factor"

From
From
Sensorineural Hearing Loss - Pipeline Insight, 2024 - Product Thumbnail Image

Sensorineural Hearing Loss - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
From
From
Trk (TrkB) receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Trk (TrkB) receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Alpha 1 adrenergic receptor antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha 1 adrenergic receptor antagonist - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Huntingtin - Pipeline Review, H2 2020 - Product Thumbnail Image

Huntingtin - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 93 Pages
  • Global
From
Glial Cell Line Derived Neurotrophic Factor - Pipeline Review, H2 2020 - Product Thumbnail Image

Glial Cell Line Derived Neurotrophic Factor - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 59 Pages
  • Global
From
Beta Nerve Growth Factor - Pipeline Review, H2 2020 - Product Thumbnail Image

Beta Nerve Growth Factor - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 61 Pages
  • Global
From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
Rett Syndrome Market Report and Forecast 2024-2032 - Product Thumbnail Image

Rett Syndrome Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
From
  • 19 Results (Page 1 of 1)
Loading Indicator

The Neurotrophic Factor market is a subset of the Central Nervous System Drugs market, which focuses on treatments for neurological disorders. Neurotrophic Factors are proteins that promote the growth and survival of neurons, and are used to treat a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Neurotrophic Factors are typically administered through injections, and can be used to replace lost or damaged neurons, or to stimulate the growth of new neurons. The Neurotrophic Factor market is highly competitive, with a number of companies developing and marketing treatments. Companies in the market include Biogen, Novartis, Merck, and Pfizer. Show Less Read more